Daniel W. Curry, PhD

2006-2010 The University of Tennessee, Knoxville, TN, United States 
 2011-2017 Neuroscience Emory University, Atlanta, GA 
 2017- Psychiatry Yale University, New Haven, CT 
"Daniel Curry"
Mean distance: 17.06 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blackburn JK, Curry DW, Thomsen AN, et al. (2020) Pioglitazone activates paraoxonase-2 in the brain: A novel neuroprotective mechanism. Experimental Neurology. 113234
Curry DW, Berro LF, Belkoff AR, et al. (2019) Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA). Neuropharmacology
Stutz B, Nasrallah C, Nigro M, et al. (2019) Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity. Molecular Metabolism
Curry DW, Stutz B, Andrews ZB, et al. (2018) Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease. Journal of Parkinson's Disease
Pitts EG, Curry DW, Hampshire KN, et al. (2017) (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. Psychopharmacology
Curry DW, Young MB, Tran AN, et al. (2017) Separating the agony from ecstasy: R(-)-3,4 methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice. Neuropharmacology
Curry D, Belkoff A, Howell L. (2017) Prosocial effects and neurotoxicity of (−)-3,4-methylenedioxymethamphetamine in mice Drug and Alcohol Dependence. 171: e50
Morrison KE, Curry DW, Cooper MA. (2012) Social status alters defeat-induced neural activation in Syrian hamsters. Neuroscience. 210: 168-78
See more...